QQQ   414.09 (-2.20%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   414.09 (-2.20%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   414.09 (-2.20%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   414.09 (-2.20%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)

ThermoGenesis (THMO) Competitors

$0.66
+0.01 (+1.94%)
(As of 01:48 PM ET)

THMO vs. NTBL, WINT, CYCC, CNSP, SLRX, NAOV, NMRD, HSTO, RSLS, and NUWE

Should you be buying ThermoGenesis stock or one of its competitors? The main competitors of ThermoGenesis include Notable Labs (NTBL), Windtree Therapeutics (WINT), Cyclacel Pharmaceuticals (CYCC), CNS Pharmaceuticals (CNSP), Salarius Pharmaceuticals (SLRX), NanoVibronix (NAOV), Nemaura Medical (NMRD), Histogen (HSTO), ReShape Lifesciences (RSLS), and Nuwellis (NUWE). These companies are all part of the "medical" sector.

ThermoGenesis vs.

ThermoGenesis (NASDAQ:THMO) and Notable Labs (NASDAQ:NTBL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment and dividends.

Notable Labs has lower revenue, but higher earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.44M0.22-$11.27MN/AN/A
Notable Labs$310K7.09-$11.26M-$3.63-0.27

5.8% of ThermoGenesis shares are owned by institutional investors. Comparatively, 70.5% of Notable Labs shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Comparatively, 1.2% of Notable Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

ThermoGenesis received 21 more outperform votes than Notable Labs when rated by MarketBeat users. However, 100.00% of users gave Notable Labs an outperform vote while only 60.47% of users gave ThermoGenesis an outperform vote.

CompanyUnderperformOutperform
ThermoGenesisOutperform Votes
26
60.47%
Underperform Votes
17
39.53%
Notable LabsOutperform Votes
5
100.00%
Underperform Votes
No Votes

Notable Labs has a net margin of 0.00% compared to ThermoGenesis' net margin of -148.15%. Notable Labs' return on equity of -62.07% beat ThermoGenesis' return on equity.

Company Net Margins Return on Equity Return on Assets
ThermoGenesis-148.15% -402.05% -78.71%
Notable Labs N/A -62.07%-48.32%

ThermoGenesis currently has a consensus target price of $5.00, indicating a potential upside of 654.60%. Notable Labs has a consensus target price of $8.00, indicating a potential upside of 716.33%. Given Notable Labs' higher probable upside, analysts clearly believe Notable Labs is more favorable than ThermoGenesis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ThermoGenesis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Notable Labs
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

ThermoGenesis has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500. Comparatively, Notable Labs has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.

In the previous week, Notable Labs had 5 more articles in the media than ThermoGenesis. MarketBeat recorded 6 mentions for Notable Labs and 1 mentions for ThermoGenesis. Notable Labs' average media sentiment score of 0.04 beat ThermoGenesis' score of -0.95 indicating that Notable Labs is being referred to more favorably in the news media.

Company Overall Sentiment
ThermoGenesis Negative
Notable Labs Neutral

Summary

Notable Labs beats ThermoGenesis on 11 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THMO vs. The Competition

MetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ Exchange
Market Cap$2.08M$51.43M$4.80B$7.36B
Dividend YieldN/AN/A2.92%4.01%
P/E RatioN/A5.94201.7915.49
Price / Sales0.220.342,475.0989.11
Price / CashN/A28.1146.8834.82
Price / Book0.211.404.554.17
Net Income-$11.27M-$5.27M$103.81M$214.16M
7 Day Performance-19.20%-7.90%-4.16%-3.32%
1 Month Performance-7.97%1.61%-5.76%-3.78%
1 Year Performance-69.61%29.85%6.75%3.58%

ThermoGenesis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NTBL
Notable Labs
2.8553 of 5 stars
$0.99
-16.2%
$8.00
+712.1%
N/A$2.19M$310,000.00-0.2713
WINT
Windtree Therapeutics
0.2665 of 5 stars
$0.42
flat
N/A-94.9%$2.17MN/A-0.0220Stock Split
News Coverage
Gap Down
CYCC
Cyclacel Pharmaceuticals
1.2855 of 5 stars
$1.67
+6.4%
$21.00
+1,157.5%
-81.3%$2.20M$420,000.00-0.062,018Analyst Report
Gap Down
CNSP
CNS Pharmaceuticals
0 of 5 stars
$0.21
-16.1%
N/A-90.0%$2.22MN/A-0.043Positive News
Gap Down
SLRX
Salarius Pharmaceuticals
0 of 5 stars
$0.50
flat
N/A-73.7%$2.16M$1.84M-0.112Negative News
Gap Down
NAOV
NanoVibronix
0 of 5 stars
$0.77
-3.7%
N/A-77.6%$2.14M$2.28M-0.369Gap Down
NMRD
Nemaura Medical
1.6866 of 5 stars
$0.07
flat
$2.50
+3,273.8%
-90.7%$2.14M$80,000.00-0.1936Gap Up
HSTO
Histogen
0 of 5 stars
$0.50
flat
N/A-52.8%$2.14M$3.77M-0.187News Coverage
RSLS
ReShape Lifesciences
0.3512 of 5 stars
$0.16
flat
$8.00
+4,853.6%
-94.5%$2.12M$8.68M0.0029Gap Down
NUWE
Nuwellis
0 of 5 stars
$0.34
-8.2%
N/A-94.2%$2.28M$8.86M-0.0259Gap Down

Related Companies and Tools

This page (NASDAQ:THMO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners